Factors influencing variability of localisation of antibodies to carcinoembryonic antigen (CEA) in patients with colorectal carcinoma - implications for radioimmunotherapy
1992

Factors Influencing Antibody Localization in Colorectal Cancer

Sample size: 56 publication Evidence: moderate

Author Information

Author(s): G.M. Boxer, R.H.J. Begent, A.M.B. Kelly, P.J. Southall, S.B. Blair, N.A. Theodorou, P.M. Dawson, J.A. Ledermann

Primary Institution: Royal Free Hospital School of Medicine

Hypothesis

What factors influence the localization of antibodies to carcinoembryonic antigen (CEA) in patients with colorectal carcinoma?

Conclusion

The study found that antibody localization varies significantly among patients and is influenced by factors such as time interval between injection and surgery.

Supporting Evidence

  • Antibody localization was inversely correlated with the time interval between injection and operation.
  • Significant correlations were found between injected activity in tumor and blood.
  • Variability in tumor to blood ratios suggests other factors influence antibody targeting.

Takeaway

Doctors are trying to understand why some cancer treatments work better for some patients than others, especially how well antibodies can find and stick to cancer cells.

Methodology

The study involved administering radiolabelled antibodies to patients and measuring their localization in tumors through surgery and gamma counting.

Potential Biases

Potential biases may arise from the selection of patients and the variability in tumor characteristics.

Limitations

The study's findings may not apply to all types of tumors or patients, and the sample size is limited to colorectal carcinoma.

Participant Demographics

Patients were adults diagnosed with colorectal carcinoma.

Statistical Information

P-Value

0.004

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication